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Abstract
Background Massive soft tissue loss involving the pelvis
and extremities from trauma, infections, and tumors
remains a challenging and debilitating problem. Although
vacuum-assisted closure (VAC) technology is effective in
the management of soft tissue loss, the adjunct of a silver
dressing in the setting of massive wounds has not been as
well tested.
Questions/purposes Does a silver negative pressure
dressing used in conjunction with a wound VAC decrease
(1) the length of acute hospital stay and overall length of
treatment; (2) the number of surgical de´bridements the
patients underwent as part of their care; and (3) the like-
lihood of wound closure without soft tissue transposition?
Methods We evaluated 42 patients with massive ([ 200
cm2) pelvic and extremity wounds from trauma, infection,
or tumor who were treated with the wound VAC with or
without a silver negative pressure dressing between January
2003 and January 2010; the first 26 patients were treated
with the wound VAC alone, and in the final 16 consecu-
tively treated patients, the silver dressing was added to the
regimen. We reviewed medical records to determine length
of treatment as well as the number and type of surgical
interventions these patients underwent. We compared the
group treated with the wound VAC alone with those
patients treated with the wound VAC and silver negative
pressure dressing.
Results Hospital stay averaged 19 days in the VAC only
group and 7.5 days in the VAC with silver dressing group
(p \ 0.041), length of overall treatment averaged 33 days
in the VAC only group and 14.3 days in the VAC with
silver dressing group (p \ 0.022), number of operative
de´bridements averaged 7.9 in the VAC alone group and
4.1 in the VAC with silver dressing group (p \ 0.001),
and success of wound closure without soft tissue trans-
position was 16 of 26 patients in the VAC alone group
and three of 16 patients in the VAC with silver dressing
group (p \ 0.033).
Conclusions Based on the reduced length of care and the
number of surgical procedures these patients with massive
wounds of the pelvis and extremities underwent, we now
use the silver negative pressure dressing in combination
with the wound VAC as part of routine care of such
patients. These results may be used as hypothesis-gener-
ating data for future randomized studies.
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Introduction
Massive pelvic and extremity soft tissue loss remains a
complex and cumbersome problem. Infection, trauma, and
tumors are common etiologies and may result in a pro-
longed course of treatment resulting from delayed healing,
persistent drainage, pain, and other complications [1, 4, 16,
17, 20]. Dressing changes and the need for repeat surgical
de´bridement often result in extensive hospital costs,
increased pain, and deconditioning of patients. Soft tissue
rotational and free flaps may be used; however, there is
often harvest site morbidity, extensive operative time, and
prolonged hospitalization [6, 19].
Vacuum-assisted closure (VAC) technology has been
shown to be effective in the management of soft tissue loss
from infections, vascular insufficiency, radiation-induced
soft tissue necrosis, and traumatic disorders [1, 28, 29, 32].
Additionally, the advent of a portable VAC unit allows
patients to mobilize earlier and expedites the return to
maximal function. It has been shown that bacterial colo-
nization can increase with wound VAC therapy, possibly
resulting in delayed or impaired healing [25, 26, 33]. The
use of a silver negative pressure dressing in conjunction
with the VAC may inhibit the colonization of drug-resis-
tant organisms and sustain early granulation leading to
expedited healing [27, 29–31]. There is little evidence that
bacteria develop resistance from continuous exposure to
silver concentrate [18, 20–24]. Silver has been associated
with reduced inflammation and modulation of matrix
metalloproteinases in studies regarding the effects on burn
patients [10, 15].
SilverlonTM (Cura, Chicago, IL, USA) is a highly con-
centrated negative pressure dressing that is a knitted
fabric material that has been silver-plated by means of a
proprietary autocatalytic chemical (reduction-oxidation)
plating technique. This technique coats the entire surface of
each individual fiber from which the dressing is made,
resulting in a very large surface area for the release of ionic
silver. Silverlon has been shown to reduce surgical site
infection [8, 11]. This technology avoids the deposition of
silver crystals in the wound and has not been shown to be
cytotoxic or to cause skin discoloration. We are not aware
of any prior studies comparing the wound VAC with and
without a silver negative pressure dressing in the treatment
of massive wounds of the pelvis and extremities. Accord-
ingly, we sought to determine whether a silver negative
pressure dressing used in conjunction with a wound VAC
decreases (1) the length of acute hospital stay and overall
length of treatment; (2) the number of surgical de´bride-
ments the patients underwent as part of their care; and
(3) the likelihood of wound closure without soft tissue
transposition.
Importantly, we have studied the use of the VAC before
[29]; five patients from that report are included in this
report, with additional clinical followup, as part of the
control group (the group treated with the wound VAC but
without the silver negative pressure dressing).
Patients and Methods
Between January 2003 and January 2010, 42 patients were
treated for massive pelvic and/or extremity wounds and
were managed with the VAC device (KCI, San Antonio,
TX, USA) by one surgeon (HJS). All patients with soft
tissue defects [ 200 cm2 involving the pelvis and/or
the extremity that were treated with wound VAC therapy
were included. The study group included 28 males and
14 females with an age range of 20 to 72 years (mean,
50 years). In this series, the first 26 patients were treated
using the wound VAC alone, and in the last 16 consecutive
patients, a SilverlonTM negative pressure dressing was used
(Fig. 1).
The most common etiologies of soft tissue loss were
infection (22), tumor (14), and trauma (six). Soft tissue
infections were associated with a metal implant or pros-
thesis in 18 of 42 (43%) patients. All metal implants and/or
prostheses were removed at the initial de´bridement. Anti-
biotic-impregnated spacers were placed during the wound
management period. To date, six of the 18 patients with metal
implants have undergone a second-stage reimplantation
Fig. 1 Basic wound VAC and silver negative pressure dressing setup
is shown. The silver fabric dressing is placed between the VAC
sponge and the wound. It is then sealed with an impervious sticky
dressing.
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procedure. Twelve of 18 continue to have an antibiotic spacer
in place. Eleven patients had a history of local radiation and
12 had a history of immunosuppression from either chemo-
therapy or organ transplantation. Twenty-two had surgical
de´bridements before referral and 26 patients were on antibi-
otics before referral. The most common organisms cultured
were sensitive Staphylococcus aureus (11), methicillin-
resistant S aureus (nine), Enterococcus faecalis (eight), and
Staphylococcus epidermidis (seven). Infectious disease con-
sultation was obtained after the initial de´bridement once
initial cultures were obtained.
Before initiation of VAC therapy, de´bridement of
necrotic and/or infected tissue was performed in the
operating room (OR) when indicated. In some instances,
patients returned to the OR for serial de´bridements with
VAC replacement. The VAC was changed at regular 2- to
3-day intervals for the wound VAC only group and every
7 days in the silver negative pressure dressing subgroup.
The current recommendation for wound VAC manage-
ment is to change the sponge no more than 72 hours
because it can be difficult to remove as a result of
overgrowth of exuberant granulation tissue. This is par-
ticularly important if the VAC dressing is to be performed
as an outpatient, because removal after 72 hours may
cause bleeding, pain, or retention of a portion of the
sponge. A foul smell is also frequently appreciated with
the VAC dressing, particularly if it is changed at intervals
[ 48 hours. The silver negative pressure dressing sub-
stantially slows the granulation ingrowth into the sponge
and may be left on up to 7 days. The VAC dressings were
either changed in the inpatient setting by a physician or as
an outpatient by skilled nursing. The VAC change was
performed under sterile technique in the OR if de´bride-
ment was required. Otherwise it was changed in a clean
but nonsterile environment either at the bedside or at the
patient’s home. Patients were allowed to ambulate with a
portable VAC unit and encouraged to do so. Wound
measurements were recorded at each VAC change by
either a physician or skilled nurse.
Treatment (whether with the wound VAC alone or with
the wound VAC plus silver negative pressure dressing)
continued until wound healing was accomplished by either
primary or secondary intention, skin grafting, or soft tissue
transposition. The minimum followup was 12 months
(average, 35.3 months; range, 12–96 months).
The surgical technique for the silver dressing application
is variable depending on the location and size of the
wound. The dressing is a fabric material and easily cut into
shapes to fit all wound geometries. It is recommended that
the entire open wound be covered by the silver dressing as
well as a portion of the surrounding skin. By overlaying the
skin, it will protect it from the overlying VAC sponge. This
will reduce skin irritation, breakdown, and maceration. The
silver fabric dressing does not require fixation to the skin.
The sponge is applied over the silver dressing and the
application is completed by covering the sponge with an
impervious sticky dressing. The wound VAC is then set to
125 mmHg on continuous mode. When removed the suc-
tion should be turned off or occluded and the dressing
removed as one unit. Complex areas including the peri-
neum, sacrum, and buttock were managed with VAC
sponges secured in position with widely spaced circum-
ferential staples and the impervious dressing was adhered
to the skin with stoma paste (Convatec, Princeton, NJ, USA
[29] (Fig. 2). Minor complications were reported in both
VAC alone and silver dressing with VAC groups. As
mentioned earlier, five patients were included in this study
whose earlier results were published previously [29]. In
this report, we extend followup on these five patients by a
mean of 32 months (range, 16–45 months). All of these
patients were treated in the wound VAC group without
silver negative pressure dressings.
Institutional review board approval was obtained and
patients gave consent for the use of their medical
Fig. 2A–B (A) Photograph of a large fungating mass involving the
adductor compartment. The patient was treated with neoadjuvant
chemotherapy and radiation followed by wide resection. A wound
VAC with silver negative pressure dressing was applied for 3 weeks
followed by primary closure. (B) Postoperative photograph showing
primarily closed wound after 3 weeks of wound VAC treatment. The
incision healed without further intervention.
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information for purposes of this study. The parameters
evaluated included size of the soft tissue defect, duration of
treatment, and patient compliance. Compliance was
determined as per home nursing records and patient inter-
view. Student’s t-test and log rank were used to determine
statistical significance. Tests were considered significant if
the p value was \ 0.05.
Results
The VAC with silver dressing group had shorter hospital-
izations than the VAC only group (Table 1). The
hospitalization for the VAC alone group was 19 days
(range, 1–31 days) and for the VAC with silver negative
pressure dressing 7.5 days (range, 2–22 days; p = 0.022).
The average length of hospitalization for all patients was
8.1 days (range, 1–31 days).
The VAC with silver dressing group underwent fewer
surgical de´bridements. The group treated with the VAC
alone had 7.9 (range, 3–12) and the group with the VAC
with silver negative pressure dressing had 4.1 (range, 2–9;
p \ 0.001). The average number of surgical de´bridements
for all patients was 5.1 (range, 1–12).
Patients treated with the VAC plus silver underwent
fewer soft tissue flaps for coverage (16 of 26 [62%] versus
three of 16 [19%]; p = 0.024). Skin grafts were used in
11 of 26 (42.3%) patients in the VAC only group; nine of
11 (82%) healed without complication and nine of 16
(56.3%) patients in the silver group had skin grafts; all
healed without complication. Twenty-two of 46 (47.8%)
patients healed by secondary intention without the need for
skin grafting (Fig. 3). Home health records indicated
excellent compliance with only two of the 42 (4.7%)
patients requesting discontinuation.
Since our previous publication [29], the five patients
who were included in that earlier article have had a mean
of 32 months additional followup (range, 16–45 months).
These patients continue to have close followup for soft
tissue sarcoma surveillance. None has been readmitted for
wound complications and none has undergone further
surgical procedures associated with wound complications.
Discussion
The use of silver dressings has gained popularity in recent
years [3, 5, 7, 9, 10]. There are several theoretical advan-
tages including an antimicrobial inhibition and enhancement
of soft tissue granulation [2, 12–14]. The prevalence of
antibiotic-resistant organisms continues to rise; the antimi-
crobial effect of the local environment may be essential.
Silver-resistant organisms have been reported but are
extremely rare [27–29]. However, microbial resistance to
silver remains somewhat controversial. It appears that silver
negative pressure may be successfully used with a reduction
of the frequency of dressing changes and reduction of a
malodorous smell often reported with the use of wound
VACs. The use of silver dressings has been substantiated as
an adjunct in complex wounds [18, 20, 22], although it has
not been studied in the setting of massive wounds such as
those we evaluated. In this report we compared the use of
the wound VAC with and without a silver negative pressure
dressing in terms of length of care and the frequency with
which surgical procedures were needed as part of that care.
This study had a number of limitations. First, because it
was not a randomized controlled study, it is possible that
some selection bias (among other kinds of bias) affected
the decision to use the treatments under study. However,
the fact that this was a sequential series should have offset
some of the selection bias. It is important to note also that
the patients had large soft tissue defects from different
etiologies. However, they were comparably sized and all in
compromised patients, and the etiologies did not vary over
Table 1. Comparison of patient outcomes undergoing wound VAC treatment with and without silver negative pressure dressing
Variable VAC only [26] VAC + silver
dressing [16]
p value
Defect size (cm2; mean) 310.4 (200–611) 345.6 (220–500) 0.124
Immunosuppressed* 7 (26.9%) 5 (31.2%) 0.224
Radiation 8 (30.7%) 3 (18.8%) 0.073
Location
Pelvis 14 (53.8%) 7 (43.8%) 0.612
Extremity 12 (46.2%) 9 (56.2%) 0.497
Surgical procedures 7.9 (3–12) 4.1 (2–9) \ 0.015
Treatment (days) 33.0 (5–91) 14.3 (7–30) \ 0.001
Average hospitalization (days) 19.1 (1–31) 7.5 (2–22) \ 0.033
Soft tissue flaps 16 (61.5%) 3 (18.8%) \ 0.024
Ranges shown in parentheses; * history of either chemotherapy or organ transplantation; VAC = vacuum-assisted closure.
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the course of the study. Related to that, wound character-
istics (such as shape), adjuvant therapies, and host factors
were not specifically evaluated or controlled; however, the
study groups showed no significant differences in terms of
immunosuppression, history of radiation, wound location,
and size. Additionally, the study groups are relatively
small; however, they were sufficiently large to allow us to
detect significant differences between them. Finally,
because this study involved a comparison of patients
treated in two sequential series, the comparisons neces-
sarily were historical. It is possible, if not likely, that other
changes to treatments would have come into play during
the time period in question, and it is possible, if not likely,
that those cotreatments would have tended to inflate the
apparent beneficial effects of silver dressings. Changes in
hospital and outpatient care patterns likely also influenced
issues such as duration of hospitalization over the period of
time considered in this study.
To our knowledge, this is the only report of the use of
the VAC in conjunction with a silver negative pressure
dressing. The addition of a silver negative pressure dress-
ing reduced the length of hospitalization compared with the
VAC alone. The frequency in which the wound VAC is
changed is reduced to weekly compared with two to three
times per week. Additionally, the inhibition of granulation
tissue into the sponge of the VAC appears to reduce the
incidence of bleeding and pain that can be associated with
the VAC sponge when used alone. Silver templated
dressing technology has been mostly studied in chest,
burns, and spine surgery with success in terms of reduced
incidence of infection [8, 10, 11, 15]. These studies eval-
uated the topical application of this technology; however,
the perforated, permeative dressing design that allows for
the application of negative pressure by a VAC has not, to
our knowledge, been reported before the present study.
The number of required surgical de´bridements used in
the VAC with silver dressing likewise was reduced in our
study. To our knowledge, there have not been previous
reports specifically addressing this; however, the inhibition
of bacterial colonization by the silver may be a contribut-
ing factor [2, 23, 27]. Surgical de´bridement of necrotic
tissue remains an essential component of treatment.
Reducing the frequency of VAC dressing changes to
weekly in the VAC with silver dressing group may have
protected the surgical wound from bacterial colonization
during the hospitalization.
The use of wound VAC technology in conjunction with
soft tissue transposition has been previously reported
[16, 19, 29]. However, to our knowledge, there have not
been prior reports of the use of silver dressings in con-
junction with the wound VAC that address the use of soft
tissue flaps. In our study, we observed a reduction in the
use of soft tissue transposition in the VAC with silver
dressing group. Only three of 16 patients (19%) in the VAC
with silver dressing group required surgical intervention for
soft tissue coverage compared with 16 of 26 (62%) in the
VAC group without silver.
The VAC appears to facilitate soft tissue healing in
patients with large, complex wounds. Patients should be
prepared in advance that it may require a lengthy,
Fig. 3A–C (A) Preoperative
photograph of a patient with
massive chondrosarcoma recur-
rence involving the pelvis,
perineum, and thigh. Late ische-
mic/necrotic changes are seen. A
hemipelvectomy with perineum/
genital resection was performed.
(B) Intraoperative photograph
after resection. The massive
wound was initially managed
with a wound VAC with silver
negative pressure dressing fol-
lowed by skin grafting. (C)
Postoperative photograph 8 weeks
postoperatively from resection. A
well-healed skin graft is shown.
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cumbersome treatment; however, use of this tool appears to
improve wound healing potential. The adjunct use of silver
negative pressure appears to reduce the overall duration of
care and decrease the likelihood that the patient will have
other surgical procedures during treatment.
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